CLINICAL_TRIALS
trial_result
· 2022-10-06
Clinical Trial Update: Trial of Roflumilast in Asthma Management (TRIM) [Phase 2]
Summary
A Phase 2 trial update on roflumilast for asthma management has completed, with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Asthma, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2022-10-06